OI
BIO icon

Oakbrook Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Oakbrook Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,050
Closed -$759K – 136
2019
Q4 		$759K Sell
2,050
-300
-13% -$106K 0.15% 193
2019
Q3 		$782K Buy
+2,350
New +$767K 0.05% 288
2019
Q2 		– Sell
-2,200
Closed -$672K – 603
2019
Q1 		$672K Buy
2,200
+1,050
+91% +$283K 0.04% 335
2018
Q4 		$267K Sell
1,150
-1,450
-56% -$389K 0.02% 498
2018
Q3 		$814K Buy
2,600
+700
+37% +$217K 0.05% 339
2018
Q2 		$548K Buy
1,900
+1,025
+117% +$283K 0.03% 334
2018
Q1 		$219K Hold
875
– – 0.01% 533
2017
Q4 		$209K Sell
875
-850
-49% -$206K 0.01% 536
2017
Q3 		$383K Buy
1,725
+50
+3% +$11.3K 0.02% 395
2017
Q2 		$379K Buy
+1,675
New +$365K 0.03% 377
2015
Q4 		– Sell
-1,907
Closed -$256K – 548
2015
Q3 		$256K Buy
1,907
+50
+3% +$7.2K 0.02% 469
2015
Q2 		$280K Buy
+1,857
New +$266K 0.02% 460
2014
Q3 		– Sell
-1,877
Closed -$225K – 536
2014
Q2 		$225K Sell
1,877
-450
-19% -$54.9K 0.01% 550
2014
Q1 		$298K Sell
2,327
-115
-5% -$14.7K 0.01% 484
2013
Q4 		$302K Sell
2,442
-250
-9% -$30.5K 0.01% 486
2013
Q3 		$316K Sell
2,692
-500
-16% -$59K 0.01% 484
2013
Q2 		$358K Buy
+3,192
New +$374K 0.01% 503

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Oakbrook Investments's BIO Position: Q1 2020 in Review

Oakbrook Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2020, closing a stake of 2,050 shares — an estimated $759K sold.

Oakbrook Investments first reported a position in BIO in Q2 2013 and held it in 17 quarters. The position peaked at $814K in Q3 2018. 406 funds tracked by Wall St. Rank hold BIO as of Q1 2020.

  • Oakbrook Investments reported no remaining Bio-Rad Laboratories Class A position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 2,050 Bio-Rad Laboratories Class A shares in Q1 2020, an estimated $759K.
  • Oakbrook Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 17 quarters.
  • Oakbrook Investments's Bio-Rad Laboratories Class A position peaked at $814K in Q3 2018.
  • 406 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.